Faraz Ali, M.B.A.

Faraz Ali, M.B.A.

Chief Executive OfficeratTenaya Therapeutics· In proxies 2022–2025

Pay in FY2025-43% from the year before · Tenaya Therapeutics stock -50.2% the same year

Faraz Ali, M.B.A. was paid $1.9M in FY2025 (Dec), down 43%. Tenaya Therapeutics stock fell 50.2% that year.

Pay$100 in the stock at the end of FY21 → $4
Pay is from the Summary Compensation Table of each Tenaya Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Tenaya TherapeuticsPublic company · 4 yr
    • Chief Executive Officer2022 – Present · 4 yrStock in role -98%
  2. Alliance for Regenerative MedicinePublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?